Nitric oxide and macrophage antiviral extrinsic activity

Immunology

Volumn 98, Issue 3, 1999, Pages 363-370

  Benencia, Fabián ^a   Courreges, M C ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOST RESISTANCE; IMMUNOREACTIVITY; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; KERATITIS, HERPETIC; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRITES; OMEGA-N-METHYLARGININE; VERO CELLS; VIRUS REPLICATION;

EID: 0032720135     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00864.x     Document Type: Article

References (41)

1. 1. HAYASHI K., KURATA T., MORISHIMA T. & NASSERY T. (1980) Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus. Infect Immun 28, 350.
2. 2. SIT M.F., TENNEY D.J., ROTHSTEIN J.L. & MORAHAN P.S. (1988) Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2. J Gen Virol 69, 1999.
3. 3. MORAHAN P.S., MORSE S. & MCGEORGE M. (1980) Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol 46, 291.
4. 4. ELLERMAN-ERIKSEN S. (1993) Autocrine secretion of interferon-α/β and tumour necrosis factor-α synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J Gen Virol 74, 2191.
5. 5. ELLERMAN-ERIKSEN S., SOMMERLUND M. & MOGENSEN S.C. (1989) Differential sensitivity of macrophages from herpes simplex virus resistant and susceptible mice to respiratory burst priming by interferon-α/β. J Gen Virol 70, 2139.
6. 6. STOHLMAN S.A., WOODWARD J.G. & FRELINGER J.A. (1982) Macrophage antiviral activity: extrinsic versus intrinsic activity. Infect Immun 36, 672.
7. 7. CROEN K. (1993) Evidence for an antiviral effect of nitric oxide. J Clin Invest 91, 2446.
8. 8. TAGUCHI F., YAMADA A. & FUJIWARA K. (1980) Resistance to highly virulent mouse hepatitis virus acquired by mice after low virulence infection: enhanced antiviral activity of macrophages. Infect Immun 29, 42.
9. 9. KARUPIAH G., XIE Q., BULLER R.M.L., NATHAN C., DUIARTE C. & MACMICKING J.D. (1993) Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445.
10. 10. NATHAN C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6, 3051.
11. 11. STUEHR D.J. & NATHAN C.F. (1989) Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 5, 1543.
12. 12. DING A.H., NATHAN C.F. & STUEHR D.J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141, 2407.
13. 13. ROLPH M.S., RAMSHAW I.A., ROCKET K.A., RUBY J. & COUDN W.B. (1996) Nitric oxide production is increased during murine vaccinia virus infection but may not be essential for virus clearance. Virology 217, 470.
14. 14. AMARO M.J., BARTOLOME J., PARDO M., COTONAT T., LOPEZ-FARRE A. & CARRENO V. (1997) Decreased nitric oxide production in chronic viral hepatitis B and C. J Med Virol 51, 326.
15. 15. LANE T.E., PAOLETTI A.D. & BUCHMEIER M.J. (1997) Dissociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol 71, 2202.
16. 16. LIN Y., HUANG Y., MA S. et al. (1997) Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 71, 5227.
17. 17. GUILLEMARD E., GENITEAU-LEGENDERE M., KERGOT R. et al. (1996) Activity of nitric oxide-generating compounds against encephalomyocarditis virus. Antimicrob Agents Chemother 40, 1057.
18. 18. HIRAOKA Y., KISHIMOTO C., TAKADA H. et al. (1996) Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase. J Am Coll Cardiol 28, 1610.
19. 19. LOWENSTEIN C.H.J., HILL S.L., LAFOND-WALKER A. et al. (1996) Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97, 1837.
20. 20. MIKAMI S., KAWASHIMA S., KANAZAWA K. et al. (1996) Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Commun 220, 983.
21. 21. PERTILE T.L. (1996) An antiviral effect of nitric oxide: inhibition of reovirus replication. Avian Dis 40, 342.
22. 22. AKARID K., SINET M., DESFORGES B. & GOUGEROT-POCIDALO M.A. (1995) Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol 69, 7001.
23. 23. BI Z., BARNA M., KOMATSU T. & REISS C.S. (1995) Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 69, 6466.
24. 24. Bi Z. & REISS C.S. (1995) Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 69, 2208.
25. 25. HARRIS N., BULLER M. & KARUPIAH G. (1995) Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 69, 910.
26. 26. MACMICKING J., XIE Q. & NATHAN C. (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15, 323.
27. 27. GOLSTEIN P. & BLOMGREEN H. (1973) Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity efficiency of very small amounts of highly purified T cells. Cell Immunol 9, 127.
28. 28. SUDO K., KONNO K., YOKOTA T. & SHIGETA S. (1994) A sensitive assay system for screening antiviral compounds against herpes simplex virus type 1 and type 2. J Virol Methods 49, 169.
29. 29. IRIE H., SHIMELD C., WILLIAMS N. & HILL T. (1993) Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunisation with live virus. J Gen Virol 74, 1357.
30. 30. BABU J.S., THOMAS J., KANANGAT S., MORRISON L.A., KNIPE D.M. & ROUSE B.T. (1996) Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 70, 101.
31. 31. BASKIN H., ELLERMAN-ERIKSEN S., LOVMAND J. & MOGENSEN S.C. (1997) Herpes simplex virus type 2 synergizes with interferon γ in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumour necrosis factor-α. J Gen Virol 78, 195.
32. 32. HIROHASHI N., RICHARDS M. & MORRISON D.C. (1996) Selective effects of serum on bacterial LPS-induced IL-6 and nitric oxide production in murine peritoneal macrophages. J Endotox Res 3, 395.
33. 33. PYO S., GANGEMI J.D., GHAFFAR A. & MAYER E.P. (1993) Poly 1:C induced antiviral and cytotoxic activities are mediated by different mechanisms. Int J Immunopharmacol 15, 477.
34. 34. STUEHR D.J. & MARLETTA M.A. (1987) Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J Immunol 139, 518.
35. 35. PARK E., SCHULLER-LEVIS G., JIA J. & QUINN M.R. (1997) Preactivation of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J Leukocyte Biol 61, 161.
36. 36. WOLFF D.J., LUBESKIE A. & LI C.H. (1997) Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with irreversible NO synthase inhibitors. Arch Biochem Biophys 338, 73.
37. 37. GOTOH T., SONOKI T., NAGASAKI A., TERADA K., TAKIGUCHI M. & MORI M. (1996) Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett 395, 119.
38. 38. COFFEY R.G., YAMAMOTO Y., SNELLA E. & PROSS S. (1996) Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem Pharmacol 52, 743.
39. 39. CABRAL G.A. & VAZQUEZ R. (1992) Delta 9 Tetrahydrocannanobiol suppresses macrophage extrinsic antiherpes activity. Proc Soc Exp Biol Med 199, 255.
40. 40. WILDY P., GILL P.G., RHODES J. & NEWTON A. (1982) Inhibition of herpes simplex virus multiplication by activated macrophages: a role for arginase. Infect Immun 37, 40.
41. 41. HRABAK A., BAJOR T., TEMESI A. & MESZAROS G. (1996) The inhibitory effect of nitrite, a stable product of nitric oxide (NO) formation, on arginase. FEBS Lett 390, 203.